— Published date: 1/6/2025
Value Proposition: Directed evolution of synthetic intrinsically disordered proteins for condensate editing.
Technology Description
Researchers at Washington University in St. Louis have developed a directed evolution method and selection strategies to enable the evolut…
— Published Date: 5/13/2025
Value Proposition: An innovative therapy leveraging unique chimeric antigen receptors (CAR) to specifically target Fc receptor-like 5 (FCRL5), enabling the precise elimination of FCRL5-expressing cells to treat multiple myeloma and other cancers.
Technology Description
…
— Published Date: 5/13/2025
Value Proposition: Plasma cell-free transcripts that can be used as biomarkers to aid in the diagnosis and monitoring of Parkinsons Disease.
Technology Description
Researchers at Washington University in St. Louis have developed a panel of cell free RNA (cfRNA) biomark…
— Published Date: 5/10/2025
Value Proposition: Method that uses plasma cfRNAs to differentiate Alzheimer’s disease from healthy controls.
Technology Description
Researchers at Washington University in St. Louis have developed a series of models using blood-based biomarkers to detect Alzheimer&…
— Value Proposition: Engineered iNKT cells with potential as a “universal” source of immune effector cells to treat cancer.
Technology Description
Researchers at Washington University in St. Louis have developed a new composition of matter that uses gene-edited invariant natural kill…
| Name | # Summaries | Author |
|---|---|---|
| 15 | ||
| 13 | ||
| 15 | ||
| 26 | ||
| 14 | ||
| 14 |
Creating...
